These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35107070)

  • 1. Sequelae following infantile haemangiomas treated with propranolol.
    Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
    Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
    Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
    J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.
    Ahogo CK; Ezzedine K; Prey S; Colona V; Diallo A; Boralevi F; Taïeb A; Léauté-Labrèze C
    Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
    Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
    Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.
    Wedgeworth E; Glover M; Irvine AD; Neri I; Baselga E; Clayton TH; Beattie PE; Bjerre JV; Burrows NP; Foelster-Holst R; Hedelund L; Hernandez-Martin A; Audrain H; Bhate K; Brown SJ; Baryschpolec S; Darne S; Durack A; Dvorakova V; Gach J; Goldstraw N; Goodyear H; Grabczynska S; Greenblatt D; Halpern J; Hearn RM; Hoey S; Hughes B; Jayaraj R; Johansson EK; Lam M; Leech S; O'Regan GM; Morrison D; Porter W; Ramesh R; Schill T; Shaw L; Taylor AE; Taylor R; Thomson J; Tiffin P; Tsakok M; Janmohamed SR; Laguda B; McPherson T; Oranje AP; Patrizi A; Ravenscroft JC; Shahidullah H; Solman L; Svensson A; Wahlgren CF; Hoeger PH; Flohr C
    Br J Dermatol; 2016 Mar; 174(3):594-601. PubMed ID: 26473312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration.
    Lie E; Püttgen KB
    Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol-resistant infantile haemangiomas.
    Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
    Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.
    Dong JY; Ning JX; Li K; Liu C; Wang XX; Li RH; Yue LL; Huang YY; Liu SH
    Sci Rep; 2017 Mar; 7(1):342. PubMed ID: 28336941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol therapy for infantile hemangioma: our experience.
    Zhang L; Wu HW; Yuan W; Zheng JW
    Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy.
    Baselga E; Roe E; Coulie J; Muñoz FZ; Boon LM; McCuaig C; Hernandez-Martín A; Gich I; Puig L
    JAMA Dermatol; 2016 Nov; 152(11):1239-1243. PubMed ID: 27540637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical propranolol for infantile haemangiomas: a systematic review.
    Price A; Rai S; Mcleod RWJ; Birchall JC; Elhassan HA
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2083-2089. PubMed ID: 29569772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas.
    Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R
    Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.